The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

Cheap Stocks: St. Jude Medical

 Dec 05, 2008 10:40 PM UTC
Return Risk
+27.62% LOW
Tracked Blogger
Symbol Sentiment Start Return Closed
STJ Positive 12/05/08 +16.79% --

Graphic_arrow1 Via BloggingStocks:  

Filed under: S and P 500, Stocks to Buy

This post is part of a series featuring bargain stocks that are worth a look now. See more Cheap Stocks.


You've probably heard that heart disease is one of the leading causes of death in the U.S. I don't mean to be a total downer in bringing up this bit of trivia; in fact, the prevalence of cardiac-related illnesses is actually a boon for Minnesota-based St. Jude Medical (NYSE: STJ). The company is engaged in the design, manufacture, and distribution of various cardiovascular medical devices, including pacemakers, replacement valves, and many more.


In mid-October, St. Jude reported higher-than-expected third-quarter sales. The medical-device firm also tightened up its full-year outlook, primarily due to the effects of currency fluctuations. However, Chief Financial Officer John Heinmiller said STJ is "confident" it can meet or exceed Wall Street's 2009 earnings estimates.


St. Jude also believes it's well-insulated from macroeconomic turmoil. CEO Daniel Starks observed that his company's products address "key health concerns," which means they're hardly discretionary items. "We expect very minimal impact from the broader and economic dynamics, and think we're in a good defensive position that way," Stark noted.

Continue reading Cheap Stocks: St. Jude Medical

Cheap Stocks: St. Jude Medical originally appeared on BloggingStocks on Fri, 05 Dec 2008 17:40:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments


 Graphic_website1 Read the rest of original post »



Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch